Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®)
The maximum tolerated dose (MTD) of SON-1010 was set…Read More
You might also be interested in reading MicroStrategy CEO And Bitcoin Bull Michael Saylor Says Company Could Generate Huge Income From Its Bitcoin Holdings.